Mobilization of Stem Cells With AMD3100 (plerixafor) in Combination with G-CSF in Multiple Myeloma Patients

Trial Identifier:	LPS16586
Sponsor:	Sanofi
Start Date:	October 2021
Primary Completion Date:	December 2022
Study Completion Date:	December 2022
Condition:	Stem Cell Transplants

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	China, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.